• Home
  • NEW DAY MEDICINE
  • 1 (75) 2025
  • 27 -1 (75) 2025 - Khatamova R.S., Tosheva H.B. - ASSESSMENT OF RENAL DYSFUNCTION IN CHRONIC HEART FAILURE AND THE SIGNIFICANCE OF KIM-1

27 -1 (75) 2025 - Khatamova R.S., Tosheva H.B. - ASSESSMENT OF RENAL DYSFUNCTION IN CHRONIC HEART FAILURE AND THE SIGNIFICANCE OF KIM-1

ASSESSMENT OF RENAL DYSFUNCTION IN CHRONIC HEART FAILURE AND THE SIGNIFICANCE OF KIM-1

Khatamova R.S. - Bukhara State Medical Institute named after Abu Ali Ibn Sina

Tosheva H.B. - Bukhara State Medical Institute named after Abu Ali Ibn Sina

Resume

In chronic heart failure developed on the basis of rheumatic heart defects, inflammatory processes are long and hidden. The article compares renal hemodynamics before and after treatment in patients with chronic heart failure developed on the basis of rheumatic heart defects and ischemic heart disease. The analysis showed that resistance index is high in rheumatic heart defects. After the standard treatment with addition of sodium glucose cotransporter type 2 inhibitors in patients, the decrease of resistance index led to positive changes in kidney function. Correlations between the resistance index and a number of kidney markers were also studied.

Key words: Rheumatic heart defects, chronic heart failure, kidney hemodynamics.

First page

144

Last page

152

For citation:Khatamova R.S., Tosheva H.B. - ASSESSMENT OF RENAL DYSFUNCTION IN CHRONIC HEART FAILURE AND THE SIGNIFICANCE OF KIM-1//New Day in Medicine 1(75)2025 144-152 https://https://newdayworldmedicine.com/en/new_day_medicine/1-75-2025

List of References

  1. Andrew A. House, Christoph Wanner, Mark J. Sarnak, Ileana L. Pina, Christopher W. McIntyre, Paul Komenda, Bertram L. Kasiske, Anita Deswal, Christopher R. deFilippi, John G.F. Cleland, Stefan D. Anker, Charles A. Herzog, Michael Cheung, David C. Wheeler, Wolfgang C. Winkelmayerand Peter A. McCullough; for Conference Participants. //KDIGO execut i v e conclusions - Kidney International 2019;95:1304-1317.
  2. Bock JS, Gottlieb SS. Cardiorenal syndrome. //Circulation. 2010;121:2592-2600.
  3. Damman K, Masson S, Hillege HL, Voors AA, van Veldhuisen DJ, Rossignol P, Proietti G, Barbuzzi S, Nicolosi GL, Tavazzi L, Maggioni AP, Latini R. Tubular damage and worsening renal function in chronic heart failure. //JACC Heart Fail 2013;1:417-424.
  4. Damman K, Van Veldhuisen DJ, Navis G, Vaidya VS, Smilde TD, Westenbrink BD, Bonventre JV, Voors AA, Hillege HL. Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate. //Heart 2010;96:1297-1302.
  5. Di Lullo L, House A, Gorini A, et al. Chronic kidney disease and cardiovascular complications. //Heart Fail Rev. 2015;20:259-272.
  6. Driver TH, Katz R, Ix JH, Magnani JW, Peralta CA, Parikh CR, Fried L, Newman AB, Kritchevsky SB, Sarnak MJ, Shlipak MG, Health ABC Study. Urinary kidney injury molecule 1 (KIM-1) and interleukin 18 (IL-18) as risk markers for heart failure in older adults: the Health, Aging, and Body Composition (Health ABC) Study. //Am J Kidney Dis 2014;64:49-56.
  7. Ebner N., Jankowska E.A., Ponikowski P., Lainscak M., Elsner S., Sliziuk V. et al. The impact of iron deficiency and anaemia on exercise capacity and outcomes in patients with chronic heart failure. Results from the studies investigating co-morbidities aggravating heart failure. //Int. J. Cardiol. 2016; 6-12. DOI: 10.1016/j.ijcard.2015.11.178;
  8. Femke Waanders M.D. et al. Effect of Renin-Angiotensin-Aldosterone System Inhibition, Dietary Sodium Restriction, and/or Diuretics on Urinary Kidney Injury Molecule 1 Excretion in Nondiabetic Proteinuric Kidney Disease: A Post Hoc Analysis of a Randomized Controlled Trial //Am. J. Kidney Dis. 2009;53(1):16-25.
  9. Geng J., Qiu Y., Qin Z., Su B. The Value of Kidney Injury Molecule 1 in Predicting Acute Kidney Injury in Adult Patients: A Systematic Review and Bayesian Meta-Analysis. //J. Transl. Med. 2021;
  10. Han WK, Waikar SS, Johnson A, et al. Urinary biomarkers in the early diagnosis of acute kidney injury. //Kidney Int. 2008;73:863-869.
  11. Ichimura et al. Kidney injury molecule-1 (KIM-1), a putativeepithelial cell adhesion molecule containing a novel immunoglobylindomain, is up-regulated in renal cells after injury //J. Biol. Chem. 1998;273(7):4135-4142.
  12. Jungbauer C.G., Birner C., Jung B., Buchner S., Lubnow M., von Bary C., Endemann D., Banas B., Mack M., Bцger C.A., Riegger G., Luchner A. Kidney injury molecule-1 and N-acetyl-β-D-glucosaminidase in chronic heart failure: possible biomarkers of cardiorenal syndrome //Eur. J. Heart Fail. 2011;13(10):1104-1110.
  13. Jungbauer C.G.; Birner C.; Jung B.; Buchner S.; Lubnow M.; von Bary C.; Endemann D.; Banas B.; MacK M.; Böger C.A.; et al. Kidney Injury Molecule-1 and N-Acetyl--D-Glucosaminidase in Chronic Heart Failure: Possible Biomarkers of Cardiorenal Syndrome. //Eur. J. Heart Fail. 2011;13:1104-1110.
  14. Jungbauer C.G.; Birner, C.; Jung, B.; Buchner, S.; Lubnow, M.; von Bary, C.; Endemann, D.; Banas, B.; MacK, M.; Böger, C.A.; et al. Kidney Injury Molecule-1 and N-Acetyl--D-Glucosaminidase in Chronic Heart Failure: Possible Biomarkers of Cardiorenal Syndrome. //Eur. J. Heart Fail. 2011;13:1104-1110.
  15. Jung S, Bosch A, Kolwelter J, Striepe K, Kannenkeril D, Schuster T, Ott C, Achenbach S, Schmieder RE. Renal and intraglomerular haemodynamics in chronic heart failure with preserved and reduced ejection fraction. //ESC Heart Fail. 2021 Apr;8(2):1562-1570. doi: 10.1002/ehf2.13257. Epub 2021 Feb 9. PMID: 33559346; PMCID: PMC8006684.
  16. Jungbauer, C.G.; Birner, C.; Jung, B.; Buchner, S.; Lubnow, M.; von Bary, C.; Endemann, D.; Banas, B.; MacK, M.; Böger, C.A.; et al. Kidney Injury Molecule-1 and N-Acetyl--D-Glucosaminidase in Chronic Heart Failure: Possible Biomarkers of Cardiorenal Syndrome. //Eur. J. Heart Fail. 2011;13:1104-1110.
  17. Jungbauer C.G., Birner C., Jung B., Buchner S., Lubnow M., von Bary C., Endemann D., Banas, B., MacK M., Böger C.A., et al. Kidney Injury Molecule-1 and N-Acetyl--D-Glucosaminidase in Chronic Heart Failure: Possible Biomarkers of Cardiorenal Syndrome. //Eur. J. Heart Fail. 2011;13:1104-1110.
  18. Jung S, Bosch A, Kolwelter J, Striepe K, Kannenkeril D, Schuster T, Ott C, Achenbach S, Schmieder RE. Renal and intraglomerular haemodynamics in chronic heart failure with preserved and reduced ejection fraction. //ESC Heart Fail. 2021 Apr;8(2):1562-1570. doi: 10.1002/ehf2.13257. Epub 2021 Feb 9. PMID: 33559346; PMCID: PMC8006684.
  19. K. Damman, S. Masson, H. L. Hillege et al., “Clinical outcome of renal tubular damage in chronic heart failure,” //European Heart Journal, 2011;32(21):2705-2712.
  20. McMurray J., McDonagh T., Morrison C.E., et al. Trends in hospitalization for the heart failure in Scotland. 1980-1990 //Eur. Heart J. 1993;14(9):1158-1162.

    file

    download